Get In Touch

Non-melanoma skin cancer occurs in the skin cells. Non-melanoma skin cancers are of different types. The most common types are basal cell carcinoma and squamous cell carcinoma. Skin cancer treatment usually involves surgery to remove the cancer cells. Certain rare types of non-melanoma skin cancer are also found; for example, merkel cell carcinoma and cutaneous T-cell lymphoma. Most often, non-melanoma skin cancer occurs in round cells called basal cells found in the top layer of the skin. This type of cancer is called basal cell carcinoma and it accounts for about 75%–80% of all skin cancers. Squamous cell carcinoma occurs in the squamous cells of the skin. These are flat cells found in the outer part of the epidermis. This type of cancer accounts for about 20% of all skin cancers. Fair-skinned individuals are highly prone to basal cell carcinoma and the rate of its incidence is increasing every year.

Factors such as high unmet needs, rising prevalence of skin cancer, government awareness programs for cancer treatment, and increasing funding activities are key drivers for the global non-melanoma skin cancer treatment market. In 2014, the American Academy of Dermatology launched a skin cancer program known as ‘Take a Hike’, which was aimed at creating awareness and resources for the academy's SPOT skin cancer initiative through crowd-sourced fundraising. Innovation of new products, increasing number of clinical trials, rising product demand, and surging health care expenditure are other factors propelling the global non-melanoma skin cancer treatment market. On the other hand, stringent regulations regarding product approval and side-effects associated with radiation therapy may hinder the global non-melanoma skin cancer treatment market during the forecast period.

The non-melanoma skin cancer treatment market has been segmented based on treatment type, application, and geography. In terms of treatment type, the market has been classified into radiation therapy, photodynamic therapy, and drug therapy. The drug therapy segment has been sub-classified into topical therapy, targeted therapy, and systemic chemotherapy. In terms of application, the non-melanoma skin cancer treatment market has been divided into basal cell carcinoma, squamous cell carcinoma, T-cell lymphoma, and others.

Geographically, the global non-melanoma skin cancer treatment market has been segregated into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global non-melanoma skin cancer treatment market, due to the large number of clinical trials, large pool of cancer patients, increasing number of cancer treatment centers, and innovation of new products. According to the University of Pennsylvania, about 2,000 people in the U.S. die of non-melanoma skin cancer every year. However, most of the times, these are people with a compromised immune system. Factors such as increasing research and development activities for cancer treatment, presence of key market players, and rising consumption of alcohol and tobacco in Europe make the region the second-largest market for non-melanoma skin cancer treatment. The market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to increasing health care expenditure, favorable government initiatives, growing medical tourism, and availability of a large number of patients for clinical trials in the region. According to Australian Journal of Dermatology, non-melanoma skin cancer is considered the most commonly diagnosed type of cancer in Australia and it is one of the most expensive cancers to treat. The approximate total cost of treatment of non-melanoma skin cancer was US$ 511 Mn in 2010, which is projected to increase to US$ 703 Mn by 2025.

Major players operating in the global market for non-melanoma skin cancer treatment are F. Hoffmann-la Roche Ltd., Novartis International AG, Merck & Co. Inc., Eli Lilly and Co., Valeant Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, and Bristol-Myers Squibb Company.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Non Melanoma Skin Cancer Treatment Market

Pre Book